FENC (Fennec) Company Cash on Hand

Graphic logo of fennecpharma.com (FENC)

Following the market launch of Pedmark, Fennec Pharmaceuticals (FENC) temporarily scaled back its R&D activity to focus on commercial scaling. The cash reserve metric illustrates this stage, with the value holding around 0.05. Effective management ensures high margins and sales transparency, while the commitment of a tight-knit circle of oncologists to the mission of protecting children's hearing guarantees stable business growth.

FENC - Fennec Pharma Company Cash Balance over the range 07/04/2022 - 11/21/2026

Financial and market metric breakdowns for Fennec Pharmaceuticals Inc. (FENC)

- current price and projected stock value:
Comprehensive company analysis:FENC Fennec Pharmaceuticals Inc
Signature product of fennecpharma.com

The commercialization of Pedmark generates a stable cash flow, which is directly reflected in the cash balance dynamics of Fennec Pharmaceuticals (FENC). This indicator captures the volume of highly liquid assets available to cover operating losses or pay dividends without relying on assumptions. The metric measures the net size of the financial reserve, excluding illiquid balance sheet items. While a high level of liquidity protects Fennec Pharmaceuticals (FENC) from default, it may signal a decline in return on equity.